Mineralys Therapeutics, Inc.
Industry: Life Sciences ・ $MLYS on Nasdaq
Insider Sale
+$141,347
-4.16%
Shares
Shares Volume: 10,757 Shares
Average Share Price: $13.14
INSIDER
Levy Adam Scott
CFO and Secretary (Officer)
reported on Jul 12 2024
traded on Jul 11 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 247,611 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $697,066.54 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 5 / 7 |
| P/S VALUE RATIO | 1.244 |
| AVERAGE SALE VALUE | $873,624.78 |
| COMPANY PREVIOUS TRADES |